Last 30 Days. BioNTech SE - ADR Stock Forecast, BNTX stock price prediction. The price target was set to $97.00 → $106.00. When BioNTech joined the Nasdaq in October 2019, its IPO raising ~$150m at a price of $15 - the company's market valuation of $3.4bn made it … The most optimistic BioNTech analyst has a price target of €135 per share, while the most pessimistic values it at €69.34. Price target in 14 days: 128.935 USD. It will come as no surprise to learn that the analysts have increased their price target for BioNTech 8.7% to €79.07 on the back of these upgrades. The brokerage currently has a market perform rating on the stock. According to TipRanks’ latest BioNTech stock prediction, based on seven analysts offering a year-long price target, the average price target for BNTX is $111.17, which represents a 13.2 percent decline from the previous price of $128.11, and is 14.4 per cent down on its 52-week high of $129.90. Over the last 30 days, this security got 1 buy, 0 sell and 0 hold ratings. Canaccord Genuity lifted their target price on shares of BioNTech from $115.00 to $130.00 and gave the company a buy rating in a research note on Monday, December 14th. BioNTech SE's share price could fall to $104.83 by Feb 4, 2022. On February 04, 2021 "SVB Leerink" gave "Market Perform" rating for BNTX. (Sharecast News) - US drug giant Pfizer and German partner BioNTech have boosted their target for producing Covid-19 vaccine doses in 2021 by more than half. The average BioNTech SE stock price prediction forecasts a potential downside of 11.18% from the current BNTX share price of $118.03. Biontech Se Sponsored Adr Stock Forecast NASDAQ:BNTX Price Target and Analyst Ratings. BioNTech SE ADR analyst estimates, including BNTX earnings per share estimates and analyst recommendations. Historical Ratings. Investment Thesis. BNTX: Get the latest BioNTech (ADRs stock price and detailed information including BNTX news, historical charts and realtime prices. In line with his bullish comments, Des Lauriers rates TRSSF shares a Buy, and has a $20 price target that implies a ~31% upside potential for the next 12 months. The upside potential (average analyst target price relative to current price) of BNTX is greater than 3.19% of stocks in the large market cap category. Finally, JPMorgan Chase & Co. set a $90.00 target price on shares of BioNTech and gave the company a neutral rating in a research note on Tuesday, November 10th. BioNTech SE's variance in analysts' estimates is lower than 3.73% of all US stocks. The average analyst price target of BNTX is greater than 89.87% of Pharmaceutical Products stocks. Most Recent Rating. BioNTech (NASDAQ:BNTX) had its price objective raised by SVB Leerink from $97.00 to $106.00 in a research report report published on Thursday, Price Targets.com reports. On average, Wall Street analysts predict that . ... Average Target Price: 97.15: Number Of …
Wheel Of Fortune Food And Drink, Dehydrating Jalapeno Peppers, National Crane Services, Benefits Of Cheese To Man, Doctor Of Pharmacy Salary In Ghana, Stoli O Vodka, Iris Module Fba Assessment Answers,
Leave a Reply